{
  "id": 7434216,
  "title": "CGHS maps domestic manufacturing capacity for 153 critical drugs to shorten supply delays",
  "url": "https://urgent.news/2026/09/15/cghs-maps-domestic-manufacturing-capacity-for-153-critical-drugs-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T01:01:04.000Z",
  "source": {
    "name": "Live Mint",
    "slug": "live-mint",
    "url": "https://www.livemint.com/news/cghs-domestic-manufacturing-capacity-153-critical-drugs-supply-delays-oncology-diabetes-muscular-atrophy-patients-11789378837821.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The health ministry of India is mapping the domestic manufacturing capacity of 153 specialized medicines to improve the availability of critical drugs for beneficiaries of the Central Government Health Scheme (CGHS), according to two government officials and a reviewed document. This initiative aims to shorten supply delays and ensure a steady supply of essential medicines to those who need them. Priyanka Sharma, a journalist at Mint, has provided insight into this development, highlighting the government's efforts to boost domestic manufacturing and streamline the distribution of important drugs.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}